Badar M. Mian, MD

Mian is professor of surgery in the division of urology at Albany Medical College in New York.


Consider financial toxicity when recommending novel hormonal therapies for prostate cancer

September 27, 2022

"Ultimately, it will be the treating physician’s responsibility to identify cost-effective alternatives and available resources to help mitigate the financial toxicity incurred from novel cancer therapies," writes Badar M. Mian, MD.

Do 5-ARIs protect against death from prostate cancer?

August 12, 2022

"It is evident...that the safety of 5-ARIs as it relates to prostate cancer outcomes is contingent upon the clinician understanding its effect on PSA level and making appropriate adjustments to ensure timely deployment of diagnostic imaging and biopsy," writes Badar M. Mian, MD.